共 353 条
[1]
Almoguera C(1988)Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 549-554
[2]
Shibata D(2011)A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer Cancer Chemother Pharmacol 67 891-897
[3]
Forrester K(2008)Pancreatic stellate cells – role in pancreas cancer Langenbecks Arch Surg 393 891-900
[4]
Martin J(2004)ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface FEBS Lett 569 332-336
[5]
Arnheim N(2009)Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer J Clin Oncol 27 663-671
[6]
Perucho M(2007)Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition Mol Cancer Ther 6 532-541
[7]
Arnoletti JP(2010)Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3 Cancer 116 5599-5607
[8]
Frolov A(2010)Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer Clin Cancer Res 16 291-303
[9]
Eloubeidi M(2003)Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors Clin Cancer Res 9 1469-1473
[10]
Keene K(1995)Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression Clin Cancer Res 1 1413-1420